Evidence map›Paper›PMID 36425271›Full record

ArticleNuclear medicine and molecular imaging2022

Preparation of Patient Doses of [

Raviteja Nanabala, Maroor Raghavan Ambikalmajan Pillai, Buvaneswari Gopal

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Raviteja NanabalaMolecular Cyclotrons Private Limited, Puthuvype, Ernakulam, Kerala 682508 India.
Maroor Raghavan Ambikalmajan PillaiMolecular Cyclotrons Private Limited, Puthuvype, Ernakulam, Kerala 682508 India.
Buvaneswari GopalDepartment of Chemistry, School of Advanced Sciences, Vellore Institute of Technology University, Vellore, Tamil Nadu 632014 India.
Vellore Institute of Technology University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: [ Method: Results: [ Conclusion: Robust protocols for the preparation of clinical doses of [

Indexed as

[177Lu]Lu-DOTATATE[177Lu]Lu-PSMA-617Neuroendocrine tumoursProstate cancerTargeted radionuclide therapy

Identifiers

PMID36425271
PMCPMC9679127
OpenAlexW4303199016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.